Generic drug markets are set to grow over 60% by 2030, fueled by patent expirations, aging populations, and cost pressures. India and China lead production, while biosimilars are the fastest-growing segment. Learn where the opportunities and risks lie.
Callum Laird | Mar, 3 2026 Read More